Amantadine: Difference between revisions
| [pending revision] | [pending revision] |
MDElliottMD (talk | contribs) Category taxonomy ship: retag Antiparkinsonian Medicines -> Antiparkinsonism agents |
Sentence-case category link per house style (NMDA_Receptor_Antagonists → NMDA_receptor_antagonists) |
||
| Line 35: | Line 35: | ||
[[Category:Antiparkinsonian]] | [[Category:Antiparkinsonian]] | ||
[[Category:Adamantanes]] | [[Category:Adamantanes]] | ||
[[Category:NMDA | [[Category:NMDA receptor antagonists]] | ||
Latest revision as of 05:02, 23 May 2026
Antiparkinsonian
Amantadine
Symmetrel
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Antiparkinsonian
Common uses
Pharmacy
Pharmacology
Purported mechanism
NMDA antagonist; dopamine releasing agent